Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Context Diabetic kidney disease (DKD) affects nearly 40% of diabetic patients, often leading to end-stage renal disease that requires renal replacement therapies, such as dialysis and transplantation. The gut microbiota, an integral aspect of human evolution, plays a crucial role in this condition....
Saved in:
| Main Authors: | Xia-Qing Wu, Lei Zhao, Yan-Long Zhao, Xin-Yao He, Liang Zou, Ying-Yong Zhao, Xia Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Pharmaceutical Biology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13880209.2024.2351946 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How leaky is the gut in Parkinson’s disease?
by: Pascal Derkinderen, et al.
Published: (2025-07-01) -
Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension
by: Wenjun Chen, et al.
Published: (2024-12-01) -
CO‐Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity
by: Hongyang Lu, et al.
Published: (2025-05-01) -
Association of intestinal mucosal barrier function with intestinal microbiota in Spleen-Kidney Yang Deficiency IBS-D mice
by: Liwen Li, et al.
Published: (2025-04-01) -
The Role of Gut Microbiota on Intestinal Fibrosis in Inflammatory Bowel Disease and Traditional Chinese Medicine Intervention
by: Fang L, et al.
Published: (2025-05-01)